Nubexa Tesamorelin

Tesamorelin is a GHRH analog research compound with an N-terminal trans-3-hexenoic acid modification. This modification provides stability against DPP-4 degradation while preserving full GHRH receptor binding.

— Mechanism Of Action

Tesamorelin retains the full 44-amino-acid GHRH structure with the hexenoic acid stabilization. It binds GHRH receptors on pituitary somatotrophs with native potency but resists enzymatic breakdown.

— Research Applications

Used in: stabilized GHRH research, comparative GHRH analog studies, visceral lipid research models, GH/IGF-1 axis research.

— Product Specifications

Compound	Tesamorelin
Available Strengths	2mg, 5mg, 10mg, 20mg
Purity	≥99% (verified by HPLC)
Form	Lyophilized powder
Storage	-20°C, protected from light
Reconstitution	Bacteriostatic water (sold separately)
Shelf Life	36 months (lyophilized, properly stored)
Certificate of Analysis	Available upon request — contact us

— What’s Included

Sealed lyophilized vial(s) of Tesamorelin
Lot number and product information
Discreet, temperature-controlled packaging
Tracked international shipping

⚠ FOR RESEARCH USE ONLY
This product is sold strictly for laboratory research purposes. Not for human consumption, diagnosis, treatment, cure, or prevention of any disease. Not for use in food, cosmetics, household products, or as drugs. Must be 21 years or older to purchase. By placing this order you confirm that you are a qualified researcher or representative of a research organization purchasing this material exclusively for in vitro research applications.

— Mechanism Of Action

— Research Applications

— Product Specifications

— What’s Included

Reconstitution

Storage

Disclaimer